0 оценок0% нашли этот документ полезным (0 голосов)
224 просмотров16 страниц
Atropine Sulfate Anticholinergic Decreases action of the parasympathetic nervous system increasing conduction velocity (dromotropy) and heart rate (chronotropy) Do not give to patients who had anyadverse reactions that affects the movement of material through the digestive tract.
Atropine Sulfate Anticholinergic Decreases action of the parasympathetic nervous system increasing conduction velocity (dromotropy) and heart rate (chronotropy) Do not give to patients who had anyadverse reactions that affects the movement of material through the digestive tract.
Авторское право:
Attribution Non-Commercial (BY-NC)
Доступные форматы
Скачайте в формате DOC, PDF, TXT или читайте онлайн в Scribd
Atropine Sulfate Anticholinergic Decreases action of the parasympathetic nervous system increasing conduction velocity (dromotropy) and heart rate (chronotropy) Do not give to patients who had anyadverse reactions that affects the movement of material through the digestive tract.
Авторское право:
Attribution Non-Commercial (BY-NC)
Доступные форматы
Скачайте в формате DOC, PDF, TXT или читайте онлайн в Scribd
Relaxes bronchial smooth • Monitor result of serum muscles causing theophylline levels carefully bronchodilation, and increased • Monitor for clinical signs of vital capacity which has been adverse effects, particularly if impaired by bronchospasm and serum theophylline levels are air trapping not available • Ensure that diazepam is readily available to treat seizures. Amniodarone Cardiovascular drug • MonitorECG continuously Blocks Na channels at rapid during IV therapy or initiation pacing frequencies, prolongning of oral therapy myocardial cell action, potential • Monitor HR and rhythm and refractory period. Also throughout therapy causes non-competitive alpha • Assess for signs of pulmonary and beta adrenergic blockade. toxicity (Rales/crackles, Decreases sinus rate. Increase decreased breath sounds, PR and QT intervals with pleuritic friction rub, fatigue, changed T wave contour. And dyspnea, cough, pleuritic pain, reduces peripheral vascular fever) resistance. • Monitor BP frequently, hypotension usually occurs during first several hours of therapy and is related to rate of infusion. If Hypotension occurs, slow rate. Atropine Sulfate Anticholinergic • Do not give to patients who Decreases action of the had anyadverse reactions that parasympathetic nervous affects the movement of system increasing material through the digestive conduction velocity tract. (dromotropy) and heart rate • Do not give to pregnant (chronotropy), enhances women or nursing mothers conduction through the AV • Monitor VS. junction • Report increase HR Decrease bodily • Monitor for constipation, secretions oliguria. (anticholinergic effect) • Instruct to take 30 mins before meals • Monitor BP and apical pulse before administration and periodically after dose. • Eat foods high in fiber and drink plenty fluids. • Can cause photophobia • Instruct client not to drive a motor vehicle • or participate in activities requiring alertness. • Advise to use hard candy, ice chips, etc. for dry mouth. • watch out for adverse reactions: dry mouth, blurred vision, photophobia and tachycardia. Patients may also stop sweating making them prone to discomfort in warm weather. Excessive doses can lead to excessive thirst, dizziness, tremor fatigue and loss of coordination. Bricanyl Bronchodilator • Do not give to mother or fetus Acts by activating specific receptors in which prolongation of the in the airways known as beta 2 pregnancy is hazardous adrenoreceptors • Do not give to patients with hypersensitivity to this drug • Monitor VS • Assess for characteristics of respirations • Watch out for adverse reactions: Increased heart rate, Muscle cramps, Agitation, Diarrhea, Bad taste, Hyperactivity in children, Insomnia, Skin rash, Hyperglycemia
Buscopan Antispasmodic • Do not give to patients with
exerts a spasmolytic action on the myasthenia gravis, megacolon smooth muscle of the and hypersensitivity. gastrointestinal, biliary and urinary • Do not administer in patients tracts. with: untreated narrow angle glaucoma; tachycardia, hypertrophy of the prostate with urinary retention; and mechanical stenoses of the gastrointestinal tract. • Assess for condition of patient before therapy • Monitor bowel sounds • Watch out for adverse reactions: rash, itching, swelling of the hands or feet, trouble breathing, increased pulse, dizziness, diarrhea, vision problems, eye pain. Calcium Gluconate Mineral and electrolyte • Observe patient closely for Replacements or suppliments symptoms of hypocalcemia Maintain cell membrane and capillary (Paresthesia, muscle twitching, permeability. Act as an activator in laryngeospasm, colic, cardiac the transmission of nerve impulses and contraction of cardiac smooth arrhythmias) Notify physcian if and skeletal muscle. Replacement of these occur. calcium in deficiency states • Monitor BP, PR, and ECG frequently throughout parenteral therapy. May cause vasodilation with resulting hypotension, bradycardia, arrhythmias, and cardiac arrest. Dexamethasone Corticosteroid • Monitor patient’s weight, BP, Decreases inflammation mainly by and electrolyte levels stabilizing leukocyte lysosomal • Monitor patient for cushing membranes: suppresses immune goid effects response, stimulates bone marrow • Watch for depression and and influences protein, fat and psychotic episodes specially in carbohydrate metabolism high dose therapy • Inspect patient’s skin for petichae Diazepam Antiepileptic, Antxiolytic • Monitor ECG in patients Exact mechanism of action not treated with epilepticus, understood. Acts mainly at the limbic seizure may recur after initial system and recticulo-formation. control. • Report severe dizziness, weakness, hearing disturbances, difficulty voiding. Diphenhydramine Decongestant • Assess frequency and nature Acts on blood vessel, GI, respiratory of cough, lung sounds, system by antagonizing the effects of amount, and type of sputum Histamine for H1 receptor site. produced. Decreases allergic response by • Assess degree of nasal blocking Histamine causes increase stiffness, rhinorrhea and heart rate, vasodilatation, secretion. sneezing Dobutamine Adrenergics • Palpate peripheral pulses and Stimulates beta-1 (Myocardial) assess appearance of adrenergic receptors with relatively extremities routinely minor effect on HR or peripheral throughout administration blood vessels. Increase cardiac • Monitor BP,HR, pulmonary output without significantly increased capillary wedge pressure, HR cardiac output and urinary output continuously during administration • Report significant changes in VS or arrhythmias Dormicum Anxiolytic, Anticonvulsant • Use with special precautions in short-acting drug in pregnant women, neonates, the benzodiazepine class that is used elderly patients, and patients for treatment of acute seizures and who are alcoholic for inducing sedation and amnesia • Monitor VS before medical procedures. Duvadilan Vasodilator • Monitor HR and BP frequently beta-adrenergic agonist that causes direct • Let the patient know that this relaxation of uterine and vascular smooth muscle. Therefore, it's used in humans for treatment of drug may be detected in the premature labour. urine for several months after administration. Dopamine Inotropic Agent • Do not give to people with Immediate precursor of Epinephrine Hyperthyroidism, nor in in the body, exogenous presence of uncorrected administration produces direct tachyarrhythmias or stimulation of Beta-1 receptors and ventricular fibrillation variable (dose-dependent) • Take precaution in pregnant stimulation of alpha receptors women (pregnancy category (peripheral vasoconstriction), will C), hypovolemia should be cause release of norepinephrine from corrected before the storage sites. This actions results in administration increased myocardial contraction and • Monitor Vital signs and ECG cardiac output, systemic during infusion, watch for vasoconstriction as well as increase dysrhythmia and ischemia. renal blood flow and sodium • *if BP drops 30 mmHg stop excretion. infusion and report to the physician • Monitor for possible adverse reaction Digoxin Cardiac Glycoside • Do not give to people with Inhibits sodium-potassium activated Intermittent Heart block, and adenosine triphosphate, thereby hypersensitivity allowing influx of calcium into the • Take precaution in pregnant intracellular space (cytoplasm), more women (pregnancy category available calcium promotes C), renal impairment, thyroid increased force of myocardial disease, previous cardiac infarction (positive inotropic glycoside use, Hypertensive effect)resulting to increased cardiac Heart Failure, AMI output. It also acts on the CNS to • Assess for PR before giving enhance vagal tone, causing the this medication. If <60 in adult decrease of conduction speed and <90 in infant or between SA and AV nodes. significantly different, reassess. If still the same report to the physician. • Monitor cardiac status • Monitor renal function • Watch out for signs of Anorexia, GI disturbances, Gynecomastia, and tachycardia.
Epinephrine Beta2 Adrenergic Agonists • Monitor V/S. and check for
Stimulates beta receptors in lung. cardiac dysrrhythmias Relaxes bronchial smooth muscle. • Drug increases rigidity and Increases vital capacity tremor in ↑BP, ↑ HR, ↑PR • patients with Parkinson’s ↓ airway resistance. disease • Epinephrine therapy interferes with tests for urinary catecholamine • Avoid IM use of parenteral suspension into buttocks. Gas gangrene may occur • Massage site after IM injection to counteract possible vasoconstriction. • Observe patient closely for adverse reactions. Notify doctor if adverse reactiondevelop • If blood pressure increases sharply, rapid acting vasodilators such as nitrates or alpha blockers can be given to counteract Furosemide Loop Diuretic • Monitor wt., BP and PR Inhibits Na and Cl reabsorption at the • Monitor fluid, I&O, electrolyte, proximal BUN and and distal tubules and in the • CO2 levels frequently ascending loop of • WOF signs of hypokalemia Henle • Monitor uric acid levels • Monitor glucose levels esp in DM pts Hydralasine Antihypertensive • Monitor BP and PR frequently Direct acting peripheral arteriolar during initial dose and vasodilator. Decrease of BP in HPN periodically after therapy and decrease after load for patients • If PO, administer with meals to with CHF. enhance absorption • If direct IV administer undiluted. Use solution as quickly as possible after drawing through needle into syringe (changes in color after contact with metal filter) Isosorbide Dinitrate Anti-anginal, Vasodilator • Report blurred vision, Relaxes vascular smooth muscles persistent or severe headache. with a resultant decrease in venus return and decrease in arterial BP. Decreases myocardial consumption Ketorolac NSAIDS • Carefully observe patient with May inhibit prostaglandin synthesis coalgulopathies. to produce anti-inflammatory analgesic and antipyretic effect Levophed Inotropic agent • Monitor cardiac status Powerful peripheral vasoconstriction • Monitor VS specially BP and HR (Alpha-adrenergic action) and as a • Watch out for adverse effects: potent inotropic stimulator of the heart and dilator of coronary arteries (Beta- adrenergic action) Lidocaine CV drugs: Anti-arrhythmics • Assess pt before and after Anesthetic therapy Increases electrical stimulation of • Pts infusion must be on cardiac ventricle and monitor His-purkinje system by direct action • Monitor ECG, if QT or QRS on tissues, increases by 50% or more, resulting to decrease depolarization, withhold the drug automaticity • Monitor BP, check for rebound and excitability in ventricles during HPN after 1-2 hrs diastolic phase • Assess respiratory status, oxygenation and pulse deficits • Assess renal and liver function • Monitor CNS symptoms • Monitor blood levels Magnesium Sulfate Anticonvulsant • Do not give to patient if RR is >16 cpm Decreased acetylcholine released to • Use with caution in patients prevent ventricular arrhythmias and with renal impairment or to prevent or treat seizures in severe whose urine output has been preeclampsia or eclampsia. less than 100 ml in the previous 4 hours, elderly and those with severe bradyarrhythmias. • Monitor I&O. make sure urine output is 100 ml or more in 4 hrs pd before each dose • Take appropriate seizure precautions • Keep IV Ca gluconate at bedside • Watch out for adverse reactions: respiratory depression, loss of reflexes, flaccid paralysis, tetany, hypotension, cardiac arrest, heart block, bradyarrhythmias, hypocalcemia, flushing, hypothermia, diaphoresis Mefenamic Acid Analgesic, Antipyretic, Muscle • Assess patient’s level of pain Relaxant before therapy Exhibits anti-inflamatory analgesic • Assess patient’s level of pain and antipyretic activity. The exact after administration of mechanism had not been clearly medication established but many of the actions • Use in precaution in patients appear to be associated principally with renal or hepatic failure with the inhibition of prostaglandin synthesis. Methergin Oxytocin drug • Monitor uterine response Increase motor activity of the uterus • Monitor VS by direct stimulation of smooth • monitor Blood loss muscle, reducing blood loss. Metoclopramide Anitiemetic • >Do not give to patients with lowers pressure threshold for Hypersensitivity, possible GI occurrence of intestinal peristaltic obstruction or hemorrhage and reflex. Coordinates gastric, pyloric history of seizure disorders and duodenal activity to improve GI motility • >Monitor I and O • >Monitor and record for vomiting • >Watch out for adverse reaction Acute CHF, AV block, bradycardia, fluid retention, hypertension, hypotension, supraventricular tachycardia, nausea, fluid retention, incontinence, urinary frequency.
Nalbuphine Hydrochloride Opioid analgesic • >Reassess patient’s level of
Unknown. Binds with opiate pain at least 15v and 30 mins. receptors in the CNS, altering After parenteral perception of and emotional administration. response to pain. • Monitor circulatory and respiratory status and bladder and bowel control or function. • If respiration are shallow or rate is below 12 breaths per min., withhold dose and notify prescriber. • Psychological and physical dependence may occur with prolong use. Naloxone Opioid Antagonist • Assess patient’s condition used to reverse the effects of before the therapy narcotic drugs used during surgery or • Do not give to patients with to treat pain, may also be used to Respiratory depression treat narcotic drug overdose or to • Monitor VS diagnose narcotic drug addiction. • Monitor for abrupt increase or decrease in BP • Watch out for adverse reactions: chest pain or fast or irregular heartbeats;feeling light-headed, fainting;seizure (convulsions); or difficulty breathing. Paracetamol Analgesic, Antipyretic • Assess patient’s fever or pain: Decreases fever by inhibiting the Type of pain, location, effects of pyrogens on the intensity, duration, hypothalamic heat regulating center temperature, and diaphoresis and by a hypothalamic action leading • Assess allergic reactions: Rash, to sweating and vasodilatation. urticaria. If these occur, drug Relieves pain by inhibiting may have to be discontinued. prostaglandin synthesis at the CNS but does not have anti-Inflammatory action because of its minimal effect on peripheral prostaglandin synthesis. Phenergan Antihistamine • Monitor patient fro neuroleptic Phenothiazine derivative that malignant syndrome, altered competes with histamine for H1 mental status, autonomic receptor sites on effector cells. instability, muscle rigidity, and Prevents, but does not reverse hyperpyrexia. histamine mediated responses. At • Stop drug 4 days before high doses, drug also has local diagnostic skin testing anesthetic effect. because antihistamines can prevent, reduce or mask positive skin test response Phenobarbital Anticonvulsant • Do not give to patients with To enhance the inhibitory actions of hypersensitivity to this drug gamma-amino butyric acid (GABA) on • Assess for the patient’s neurons. condition before the therapy • Assess for the seizure characteristics • Monitor VS • Watch out for adverse reactions: CV: slow heartrate (bradycardia), low blood pressure (hypotension). CNS: lethargy, sedation, ataxia, or paradoxical excitement. Often dose related, these signs may subside with continued therapy. Respiratory: breathing depressed. GI: polydipsia (increase thirst)GU: polyuria (increased urine output) Skin: abscess or necrosis at injection site.
Phenytoin Anticonvulsant • Do not give to patients with
Treatment of epilepsy. The primary history of confusion or site of action appears to be the restlessness from hypnotics, or motor cortex where spread of seizure hypersensitivity, renal or activity is inhibited. hepatic impairment and severe pulmonary insufficiency • Monitor I and O • Assess for cessation of seizure • Assess renal studies • Watch out for adverse reactions: GI disturbances, slurred speech, diplopia, mental confusion with headache, dizziness Potassium Chloride Mineral and electrolyte • Assess for signs and symptoms replacement or supplement of hypokalemia (weakness, Maintain acid-base balance, fatigue, arrhythmias, polyuria) isotonicity, and electrophysiologic and hypovolemia. balance of the cell. Activator in many enzymatic reaction. Essential to • Monitor pulse, BP and ECG transmission of nerve impulses, periodically during IV therapy. contraction of cardiac skeletal and smooth muscle, gastric secretion, renal function, tissue synthesis and carbohydrate metabolism. Ranitidine H2Receptor antagonist • Administer oral drug with Competitively inhibits the action of meals histamine at the H2 receptors of the • Decrease dose in renal and parietal cells of the stomach, liver failure inhibiting basal gastric acid secretion • Provide concurrent antacid and gastric acid secretion that is therapy to relieve pain stimulated by food, insulin, • Report sore throat, fever, histamine, cholinergic agonist, unusual bruising or bleeding, gastrin and pentagastrin. tarry stools, confusion, hallucinations, dizziness, severe headache, , muscle or joint pains. Sodium Bicarbonate Anti-ulcer agent • Assess fluid balance (I and O, Acts as an alkalinizing agent by daily weight, edema, lung releasing bicarbonate ions. Following sounds) throughout therapy oral administration, releases • Report symptoms of fluid bicarbonate, which is capable of overload (HPN, edema, neutralizing gastric acid. dyspnea) if they occur Tramadol Analgesic • Control environment (Temp. Binds to mu-opioid receptors and and light) If sweating or CNS inhibits the reuptake of effects occur. norepinephrine and serotonin causes • Instruct the patient to avoid many effects similar to the opioids: driving or performing tasks dizziness, somnolence, nausea, that requires alertness constipation, but does not have the • Report severe nausea, respiratory depressant effects. dizziness, severe constipation Verapamil calcium channel blocker • Do not give to patients with Treatments of hypertension, angina Bradycardia second and third pectoris, cardiac arrhythmia, and degree atrioventricular block, most recently cluster headaches. It is heart failure, Wolff-Parkinson- also an effective preventive White syndrome medication for migraine. Verapamil • Assess patient’s condition has also been used as a vasodilator before drug therapy during cryopreservation of blood • Monitor VS and I & O vessels. • Watch out for adverse reactions: Constipation, nausea, hypotensive symptoms, ankle edema, atrioventricular block Saint Dominic College of Asia